ADAMAX

ADAMAX is described in supplier literature as an adamantane conjugate of the Semax heptapeptide, with the adamantyl group attached at the N-terminus. Semax itself is Met-Glu-His-Phe-Pro-Gly-Pro, built on the ACTH(4-7) core with a Pro-Gly-Pro stabilising extension.

Adamantane is a rigid tricyclic hydrocarbon cage, a diamond-lattice fragment of formula C10H16, and it is one of the more common lipophilicity-raising groups in synthetic organic chemistry. Attaching it to a peptide N-terminus does two things: it adds a large, chemically inert, strongly hydrophobic mass, and it caps the free alpha-amino group, which removes the substrate site for aminopeptidase trimming.

It is worth being precise about what follows from that. The N-terminal methionine of the parent peptide is not an inert position, and modifying it changes the molecule in ways that cannot be predicted from the parent sequence alone. This conjugate does not carry an entry in the primary chemical registries, and reported structural details differ between sources, so identity for a given lot rests on the analysis of that lot rather than on a database reference.

There is no substantial primary literature on this exact conjugate. What exists is the literature on the underlying Semax scaffold, which has been examined in cultured neurons and rodent brain tissue for neurotrophic gene and protein expression, including brain-derived neurotrophic factor and its receptor, and for melanocortin-linked signalling inherited from the ACTH-derived core.

Extrapolating from that work to the conjugate requires caution, because the modification sits at a position the parent literature identifies as functionally relevant. Adamantane conjugation of peptides is itself a well-established strategy in the synthetic literature, where it is used to raise lipophilicity and slow enzymatic degradation, and the general behaviour of that modification is better documented than this specific molecule is.

The conjugation is easy to confirm and difficult to fake. An adamantanecarbonyl group adds a defined mass increment of approximately 163 daltons to the parent peptide, so mass spectrometry distinguishes conjugated from unconjugated material immediately, and the presence of the parent peptide mass in a spectrum indicates incomplete conjugation.

Chromatography gives an independent check. The adamantyl cage is strongly hydrophobic, so the conjugate is markedly more retained on a reversed-phase column than the parent peptide, and the retention shift is large enough to be unmistakable. Material that elutes at the retention time of underivatised Semax has not been conjugated.

Nuclear magnetic resonance provides the most direct structural confirmation available for this compound. The adamantyl cage produces a characteristic and easily recognised cluster of aliphatic signals between roughly 1.6 and 2.1 parts per million, integrating to fifteen protons, which no peptide residue reproduces. For a molecule without a registry entry, that combination of mass increment, retention shift and proton count is what a rigorous lot analysis rests on.